Marta Compte
Recombinant Antibody Technology (United Kingdom)(GB)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Radiopharmaceutical Chemistry and Applications, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Lipopolysaccharide Activates Toll-like Receptor 4 (TLR4)-mediated NF-κB Signaling Pathway and Proinflammatory Response in Human Pericytes(2013)318 cited
- → Analysis of exosome release and its prognostic value in human colorectal cancer(2011)283 cited
- → Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity(2016)167 cited
- → A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity(2018)141 cited
- → The coming of age of engineered multivalent antibodies(2015)132 cited
- → Tumor Immunotherapy Using Gene-Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds(2008)96 cited
- → When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy(2023)93 cited
- → ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy(2017)80 cited
- → Long-term in vivo imaging of human angiogenesis: Critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels(2008)80 cited
- → Inhibition of tumor growth in vivo by in situ secretion of bispecific anti-CEA × anti-CD3 diabodies from lentivirally transduced human lymphocytes(2007)64 cited